Health Canada Accepts New Drug Submission for Trofinetide Acadia Pharmaceuticals is pleased to share that Health Canada has accepted their New Drug Submission (NDS) of trofinetide for the treatment of Rett Syndrome. Moreover, the treatment has been granted Priority Review to… Read More
Call for Art 2025 Calendar
Leave a Comment
Last Updated: 06/21/2024 by Steve
Health Canada Accepts a New Drug Submission
Leave a Comment
Last Updated: 04/24/2024 by Steve
Health Canada Accepts New Drug Submission for Trofinetide Acadia Pharmaceuticals is pleased to share that Health Canada has accepted their New Drug Submission (NDS) of trofinetide for the treatment of Rett Syndrome. Moreover, the treatment has been granted Priority Review to… Read More
2024 Grant Applications
Leave a Comment
Last Updated: 10/15/2023 by Steve